Equities

Agape ATP Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ATPC:NAQ

Agape ATP Corp

Actions
Health CareHealth Care Providers
  • Price (USD)2.64
  • Today's Change0.195 / 7.98%
  • Shares traded430.59k
  • 1 Year change-94.92%
  • Beta--
Data delayed at least 15 minutes, as of Feb 10 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Agape ATP Corporation is a Malaysia-based investment holding company. The principal activity of the Company is to supply health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging, and products designed to improve the overall health system of the human body, along with various wellness programs. The Company offers three series of programs, each consisting of different services and products: ATP Zeta Health Program, ENERGETIQUE, and BEAUNIQUE. Its ATP Zeta Health Program is a health program designed to assist in the elimination of various diseases caused by environmental pollutants, unhealthy dietary intake, and unhealthy lifestyles. The ENERGETIQUE series consists of energy mask series, hyaluronic acid, and mousse facial cleanser. Its BEAUNIQUE product series focuses on researching diet’s impact on modifying gene expressions to address genetic variations and deliver a nutrigenomic solution for every individual.

  • Revenue in USD (TTM)1.48m
  • Net income in USD-2.71m
  • Incorporated2016
  • Employees16.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nu-Med Plus Inc0.00-54.13k1.28m2.00---------0.0006-0.00060.00-0.00310.00----0.00-910.51-451.95---------------8.61--------45.55------
Escalon Medical Corp11.94m-200.38k1.33m39.00--1.29--0.1115-0.0436-0.04361.110.22592.573.677.31306,156.90-2.201.53-4.993.4845.3843.87-0.85520.70260.979-1.960.1335--0.53955.09115.88---42.12--
Leafbuyer Technologies Inc5.84m205.18k1.40m12.006.83----0.24010.0020.0020.0583-0.01426.35--71.02486,275.0022.33-44.28----44.0437.833.52-21.61--3.07----15.5420.68136.74-27.51----
Venus Concept Inc58.88m-54.61m1.49m292.00--0.5564--0.0253-46.93-46.9348.241.440.87941.213.13201,630.10-81.66-34.89-199.53-47.8164.3667.86-92.86-54.810.5934-6.680.9056---15.09-10.10-26.16---35.75--
Aethlon Medical Inc0.00-11.26m2.17m9.00--0.2955-----56.69-56.690.007.550.00----0.00-139.25-86.44-181.09-98.06-------3,662.04----0.00-------9.67------
Tivic Health Systems Inc482.00k-7.51m2.30m7.00--0.271--4.77-9.87-9.870.59143.360.10022.0734.4368,857.14-156.00-118.40-178.18-148.80-58.095.50-1,557.26-610.995.86--0.00---33.6713.1831.40------
Agape ATP Corp1.48m-2.71m2.45m16.00--0.1071--1.65-0.2994-0.29940.05230.45660.104713.9960.1492,806.88-19.46-34.76-21.27-44.4452.6869.19-185.74-92.8616.18--0.0056---7.57---17.53------
INVO Fertility Inc6.94m-27.13m2.64m28.00------0.3798-602.89-644.6750.028.630.387419.5026.14247,996.40-149.96-63.14-299.48-98.9639.1760.46-387.11-276.300.1022-10.360.2530--116.2534.57-16.33--9.88--
Work Medical Technology Group Ltd10.74m-3.71m2.67m229.00--0.0002--0.2489-2,871.58-2,871.587,811.598,868.19------46,903.67--------26.89---35.42--0.9802-8.870.4505---15.18---3,217.31------
Autonomix Medical Inc0.00-16.69m2.76m8.00--0.3844-----5.08-5.080.001.040.00----0.00-250.94---316.15--------------0.00------26.03------
Fuse Medical Inc18.40m3.63m2.96m31.001.11--0.80140.16060.0360.0360.2307-0.00310.95930.70185.75593,671.9018.910.750448.451.3564.9554.9819.720.65520.3143-1.131.12---8.67-6.72295.1134.66----
Avalon Globocare Corp1.40m-18.76m3.01m5.00------2.16-9.75-9.750.6074-1.100.0974--16.92279,216.00-131.94-76.04-1,379.37-114.3725.7023.19-1,355.20-888.890.1477-4.072.69--6.19-2.9252.69------
Encision Inc6.30m-380.94k3.19m22.00--1.71--0.5061-0.0284-0.02840.50570.11051.662.277.98286,353.60-10.05-3.17-14.19-4.4052.6451.47-6.05-2.010.9127-5.690.1094---0.464-3.0968.17--8.09--
Catheter Precision Inc730.00k-22.19m3.22m22.00--0.4687--4.41-37.38-37.380.93714.120.0281.646.3533,181.82-66.93-128.03-78.29-160.1292.60-242.70-2,393.84-15,268.880.4569-66.840.0449---4.98-19.8969.45---24.21--
ENvue Medical Inc2.69m-5.21m3.54m15.00--0.0774--1.32-83.93-83.937.4642.000.09090.83646.45179,000.00-25.01-97.63-32.90-149.1830.0253.04-275.12-397.830.6675--0.0669--12.0537.000.1617------
Data as of Feb 10 2026. Currency figures normalised to Agape ATP Corp's reporting currency: US Dollar USD

Institutional shareholders

0.17%Per cent of shares held by top holders
HolderShares% Held
Citadel Securities LLCas of 30 Sep 202565.13k0.13%
XTX Markets LLCas of 30 Sep 202510.87k0.02%
Two Sigma Investments LPas of 30 Sep 202510.84k0.02%
LPL Financial LLCas of 30 Sep 20250.000.00%
Two Sigma Securities LLCas of 30 Sep 20250.000.00%
UBS Securities LLCas of 31 Dec 20250.000.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.